Precigen (PGEN) Receivables - Other (2012 - 2026)
Precigen (PGEN) reported Receivables - Other of $302000.0 for Q1 2026, down 3.51% year-over-year from $313000.0 in Q1 2025, and down 32.29% quarter-over-quarter from $446000.0 in Q4 2025.
Precigen (PGEN) Receivables - Other (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Receivables - Other data on file, last reported at $302000.0 in Q1 2026.
- Receivables - Other for Q1 2026 came in at $302000.0, down 3.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $302000.0 (down 3.51% YoY), and the FY2025 annual result was $446000.0, up 88.19% from the prior year.
- Receivables - Other fell to $302000.0 in Q1 2026 per PGEN's latest filing, from $446000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $13.1 million in Q2 2023 and troughed at $18000.0 in Q2 2022.
- A 5-year average of $3.9 million and a median of $531500.0 in 2022 frame the typical range for Receivables - Other.
- On a YoY basis, Receivables - Other climbed as much as 72411.11% in 2023 and fell as far as 94.58% in 2023.
- A 5-year view of Receivables - Other shows it stood at $12.4 million in 2022, then sank by 94.58% to $673000.0 in 2023, then slumped by 64.78% to $237000.0 in 2024, then soared by 88.19% to $446000.0 in 2025, then plunged by 32.29% to $302000.0 in 2026.
- Business Quant data shows PGEN's Receivables - Other at $302000.0 in Q1 2026, $446000.0 in Q4 2025, and $520000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 302,000.00 |
| Mar 31, 2026 | 302,000.00 |
| Dec 31, 2025 | 446,000.00 |
| Dec 31, 2025 | 446,000.00 |
| Sep 30, 2025 | 520,000.00 |
| Sep 30, 2025 | 520,000.00 |
| Jun 30, 2025 | 244,000.00 |
| Jun 30, 2025 | 244,000.00 |
| Mar 31, 2025 | 313,000.00 |
| Mar 31, 2025 | 313,000.00 |
| Dec 31, 2024 | 237,000.00 |
| Dec 31, 2024 | 237,000.00 |
| Dec 31, 2023 | 673,000.00 |
| Dec 31, 2023 | 673,000.00 |
| Sep 30, 2023 | 12.59 Mn |
| Sep 30, 2023 | 12.59 Mn |
| Jun 30, 2023 | 13.05 Mn |
| Jun 30, 2023 | 13.05 Mn |
| Mar 31, 2023 | 12.53 Mn |
| Mar 31, 2023 | 12.53 Mn |